Interventional, Open-Label, Positron Emission Tomography (PET) Study With [11C]-Lu AF88370 Investigating Blood-Brain Barrier Penetration of Lu AF88370 in Healthy Men
Latest Information Update: 18 Jul 2022
At a glance
- Drugs Lu AF 88370 (Primary)
- Indications Unspecified
- Focus Pharmacokinetics
- Sponsors Lundbeck A/S
Most Recent Events
- 12 Jul 2022 Status changed from recruiting to completed.
- 08 May 2022 Planned End Date changed from 31 May 2022 to 6 Jun 2022.
- 08 May 2022 Planned primary completion date changed from 25 May 2022 to 6 Jun 2022.